Drugs Information: Certolizumab pegol
Basic Information
|
||
| ID | DDInter342 | |
| Drug Type | biotech | |
| Molecular Formula | C2115H3252N556O673S16 | |
| Molecular Weight | - | |
| Description | Certolizumab pegol is a tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. | |
| ATC Classification | L04AB05 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Certolizumab pegol
| Severity level | ID | Name | Mechanism | Detail |
|---|